Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Virulent coliphages in 1-year-old children fecal samples are fewer, but more infectious than temperate coliphages

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Antibiotic exposure in infancy and development of BMI and body composition in childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Charlotte King
  • Amanda McKenna
  • Niloufar Farzan
  • Susanne J Vijverberg
  • Marc P van der Schee
  • Anke H Maitland-van der Zee
  • Lambang Arianto
  • Hans Bisgaard
  • Klaus BØnnelykke
  • Vojko Berce
  • Uroš Potočnik
  • Katja Repnik
  • Bruce Carleton
  • Denise Daley
  • Fook Tim Chew
  • Wen Chin Chiang
  • Yang Yie Sio
  • Michelle M Cloutier
  • Herman T Den Dekker
  • Liesbeth Duijts
  • Johan C de Jongste
  • F Nicole Dijk
  • Gerard H Koppelman
  • Carlos Flores
  • Natalia Hernandez-Pacheco
  • Maria Pino-Yanes
  • Somnath Mukhopadhyay
  • Kaninika Basu
  • Lauren Bignell
  • Kelan G Tantisira
  • Steve Turner
  • Katia M Verhamme
  • Ben Francis
  • Munir Pirmohamed
  • Ian Sinha
  • Daniel B Hawcutt
Vis graf over relationer

A systematic review of pharmacogenomic studies capturing adverse drug reactions (ADRs) related to asthma medications was undertaken, and a survey of Pharmacogenomics in Childhood Asthma (PiCA) consortia members was conducted. Studies were eligible if genetic polymorphisms were compared with suspected ADR(s) in a patient with asthma, as either a primary or secondary outcome. Five studies met the inclusion criteria. The ADRs and polymorphisms identified were change in lung function tests (rs1042713), adrenal suppression (rs591118), and decreased bone mineral density (rs6461639) and accretion (rs9896933, rs2074439). Two of these polymorphisms were replicated within the paper, but none had external replication. Priorities from PiCA consortia members (representing 15 institution in eight countries) for future studies were tachycardia (SABA/LABA), adrenal suppression/crisis and growth suppression (corticosteroids), sleep/behaviour disturbances (leukotriene receptor antagonists), and nausea and vomiting (theophylline). Future pharmacogenomic studies in asthma should collect relevant ADR data as well as markers of efficacy.

OriginalsprogEngelsk
TidsskriftThe pharmacogenomics journal
ISSN1470-269X
DOI
StatusE-pub ahead of print - 17 jan. 2020

ID: 59065912